Gregor Diagnostics, Inc. — Form D
Gregor Diagnostics, Inc. of Dallas, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-29. The offering totals $6.6M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-10-29
- Form: D
- Accession: 0001746381-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $5.0M
- Remaining: $1.5M
- Investors: 7
- Date of first sale: 2021-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-419248
Issuer
- Name: Gregor Diagnostics, Inc.
- CIK: 0001746381
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5910 N. Central Expressway, Dallas, TX, 75206
- Phone: 608-340-1896
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Gilbert G Garcia | Director | Dallas, TX |
| Mike G Bress | Executive Officer | Dallas, TX |
| Lauren Tyra | Director | Dallas, TX |
| Lauren Tyra | Executive Officer | Dallas, TX |
| Michael Partsch | Director | Madison, WI |
| Tobias Zutz | Director | Dallas, TX |
| Tobias Zutz | Executive Officer | Dallas, TX |
| Sundaresh Brahmasandra | Director | Ann Arbor, MI |
| Steven Weinstein | Director | Dallas, TX |
| Steven Weinstein | Executive Officer | Dallas, TX |
Other filings by this issuer (5)
More